Vector Pharma Fzco company information, Employees & Contact Information

OXB kicks off US expansion, buying viral vector plant in N.C. from National Resilience for $4.5M Fierce Pharma

Andelyn Biosciences Manufactures Viral Vector with AAV Curator Platform Contract Pharma

Sarepta gene therapy vector early beneficiary of FDA platform designation FirstWord Pharma

BMS scales back at former Novartis plant, shifting cell therapy vector production to MA Fierce Pharma

Endonuclease Evaluation for Viral Vector Manufacturing: Process Impurity Control Case Study Contract Pharma

Thermo Fisher again trims workforce at Massachusetts viral vector sites FirstWord Pharma

EVERSANA™ and Vector Pharma FZCO Announce Strategic Partnership to Expand Commercialisation Services Throughout Middle East and North Africa PR Newswire

Vector Pharma FZCO signs Exclusive License and Distribution Rights to IXEMPRA in the Middle East GlobeNewswire

Novartis debuts €40M viral vector plant in Slovenia, part of €3.5B investment push in the country Fierce Pharma

Oncopeptides and Vector Pharma FZCO Announce Collaboration to Provide Pepaxti to Patients in the Middle East and North Africa Yahoo Finance

Vector Pharma FZCO Announce Exclusive Distribution GlobeNewswire

Charles River, Captain T Cell Sign Plasmid DNA & Viral Vector Production Program Agreement Contract Pharma

Thermo Fisher charts 160 layoffs in Massachusetts amid viral vector overhaul Fierce Pharma

SK pharmteco Doubles Viral Vector Production Capacity in Europe Contract Pharma

Versant bets $30M on next-gen gene delivery startup Vector Fierce Pharma

Vector Laboratories Fierce Pharma

Vector BioMed debuts as viral vector CDMO with $15M funding Fierce Pharma

Fujifilm triples down on viral vector manufacturing with new $40M Boston site Fierce Pharma

Catalent antes up $230M to expand Maryland viral vector manufacturing operation Fierce Pharma

With demand surging for lentiviral vectors, CDMO VIVEbiotech expands capacity 400% in cross-town move Fierce Pharma

Kite's viral vector ambitions take flight as the Gilead subsidiary wins FDA nod for SoCal production plant Fierce Pharma

Who are the leading innovators in CRISPR vectors for the pharmaceutical industry? Pharmaceutical Technology

Merck Partners with Vector Institute to Advance AI in Healthcare Contract Pharma

Umoja Biopharma kicks off construction on Colorado lentivirus vector production facility Fierce Pharma

The tale of two companies: One viral vector partner for every stage of gene therapy development Fierce Pharma

Vexed by vectors: How COVID-19 vaccine and cell and gene players are tackling the viral vector bottleneck Fierce Pharma

Thermo Fisher's layoff spree continues with 300 dismissals in Massachusetts Fierce Pharma

$50M cell and viral vector manufacturing operation backed by Harvard Fierce Pharma

ProBio Opens Flagship Cell & Gene Therapy Center of Excellence in Hopewell, NJ Contract Pharma

CDMO Vibalogics, speeding toward U.S. commercial plant, pumps $50M into viral vector capacity Fierce Pharma

Oxford Biomedica raises $53M to support recent buy into US viral vector manufacturer: report Fierce Pharma

AGC Biologics telegraphs 278 layoffs as it plots sale of Colorado manufacturing plants Fierce Pharma

CDMO AmplifyBio closes doors amid tough market for early-stage cell and gene therapy development Fierce Pharma

FDA restricts bluebird bio gene therapy Skysona after blood cancer reports Fierce Pharma

BioDesign: Accelerating the Momentum of Bioconjugate Therapeutics Fierce Pharma

With $71M investment, French CDMO Yposkesi set to double capacity and become a viral vector force Fierce Pharma

CDMO OXB raises £60M to support US expansion ambitions Fierce Pharma

FDA investigates patient deaths after treatment with Sarepta's Duchenne gene therapy Elevidys Fierce Pharma

CDMO National Resilience plots 120 layoffs at former bluebird bio facility in Research Triangle Park Fierce Pharma

In $2.6B cell and gene therapy expansion, Sartorius buys viral vector specialist Polyplus Fierce Pharma

Sanofi starts on viral vector facility as its R&D focus shifts to gene therapies Fierce Pharma

Emergent plots $75M expansion to produce viral vectors for expanding gene therapy business Fierce Pharma

Bayer's gene therapy CDMO Viralgen cuts ribbon on first phase of $142M viral vector expansion Fierce Pharma

Charles River inks viral vector production pact for Navega's chronic pain gene therapy Fierce Pharma

Thermo Fisher opens yet another production site, this one in Massachusetts for viral vectors Fierce Pharma

Merck KGaA amps up in gene therapy with $110M viral vector manufacturing boost Fierce Pharma

Batavia Opens GMP Production Facility in the Netherlands Contract Pharma

UPDATE: Roche overhauls Spark gene therapy unit, recording $2.4B in full impairment Fierce Pharma

With new facility and leadership, CDMO Genezen is stepping up to the big leagues Fierce Pharma

Pfizer discontinues hemophilia treatment Beqvez, emptying its gene therapy portfolio Fierce Pharma

Sarepta reports 2nd death after DMD gene therapy Elevidys, stops dosing in half of patients Fierce Pharma

Oxford Biomedica, Novartis extend lentiviral vector supply deal for CAR-T drugs Fierce Pharma

French biotech clinches €27M to engineer herpes viral vectors for genetic payloads FirstWord Pharma

Univercells, Repligen Partner to Integrate Real-Time Monitoring Capabilities Contract Pharma

Cytiva Introduces ELEVECTA Cell Lines Contract Pharma

Charles River lays out $293M to snap up viral vector specialist Vigene, its 2nd M&A deal this year Fierce Pharma

The top 10 largest biopharma M&A deals in 2020 Fierce Pharma

Amid strategic pivot, 2seventy bio plots comeback for BMS-partnered CAR-T Abecma Fierce Pharma

AstraZeneca ropes in Catalent gene therapy site to produce viral vectors for COVID-19 vaccine Fierce Pharma

With new CEO on board, Germany's Vibalogics lays out $150M for Boston viral vector site Fierce Pharma

'Like a dairy farm treats cows': Henrietta Lacks' estate hits Ultragenyx with gene therapy vector lawsuit Fierce Pharma

Avid Bioservices to build $75M plant in California for viral vectors, name new executive Fierce Pharma

In $4.1B deal, Thermo Fisher buys 3M spinoff's filtration unit to beef up bioproduction Fierce Pharma

Viral vector CDMO Vibalogics latest private equity target Fierce Pharma

MilliporeSigma boosts its gene therapy manufacturing capability with $600M acquisition of Mirus Bio Fierce Pharma

J&J, Legend expand manufacturing deal with Novartis to include commercial production of Carvykti Fierce Pharma

Sarepta reports one death after patient received DMD gene therapy Elevidys Fierce Pharma

UniQure sells gene therapy manufacturing site to Genezen, along with production of CSL's Hemgenix Fierce Pharma

Thermo Fisher plots 85 layoffs in California as its cost-cutting crusade marches on Fierce Pharma

Bluebird buys manufacturing site to produce viral vector as it advances gene therapies Fierce Pharma

J&J, Legend double CAR-T manufacturing investment to $500M as Carvykti eyes wider myeloma use Fierce Pharma

Dispatch Bio targets solid tumours with 'Flare' FirstWord Pharma

Bristol Myers hits CAR-T manufacturing bottleneck as Abecma demand outstrips supply Fierce Pharma

GE launching its viral vector factory-in-a-box prefab KUBio labs Fierce Pharma

UPDATED: Bluebird’s sickle cell gene therapy comes with safety warning and higher price. Can Lyfgenia overcome CRISPR’s halo? Fierce Pharma

Bluebird Bio hits pause on rollout for ill-fated gene therapy Zynteglo as trial flags 2 cancer cases Fierce Pharma

UPDATED: Thermo Fisher plots 74 layoffs at California plasmid manufacturing site as demand swings Fierce Pharma

2 deaths after Novartis' Zolgensma put gene therapy's liver safety in the spotlight once again Fierce Pharma